What happened
Shares of Inhibrx(NASDAQ:INBX), a clinical-stage biotechnology company, jumped when the market opened today. Investors excited about the company’s latest clinical trial readout pushed the stock 26.8% higher as of 11:29 a.m. on Tuesday. 
So…

Click here to view the original article.